Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.
One of the challenging questions in cancer biology is how a normal cell transforms into a cancer cell. There is strong evidence that specific chromosomal translocations are a key element in this transformation process. Our studies focus on understanding the developmental mechanism by which a normal...
Main Authors: | Erin H Breese, Corina Buechele, Catherine Dawson, Michael L Cleary, Matthew H Porteus |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4564237?pdf=render |
Similar Items
-
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by <i>MLL-AF4</i> Translocations
by: Kathy-Ann Secker, et al.
Published: (2020-06-01) -
CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis
by: Evgenia Sarrou, et al.
Published: (2020-06-01) -
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation
by: Cristiana Barone, et al.
Published: (2023-07-01) -
Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
by: Cano, F, et al.
Published: (2008) -
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
by: Rasmus O Bak, et al.
Published: (2017-09-01)